
Researchers investigating the development of peptic ulcers in patients with liver cirrhosis reported that H. pylori is not the predominant etiology in this population.

Citing an increased risk of liver injury observed in recent clinical trials, the US Food and Drug Administration (FDA) has limited Samsca (tolvaptan) treatment to 30 days and recommended the oral selective vasopressin V2-receptor antagonist be discontinued in patients with signs of liver disease or symptoms of liver injury.

Researchers investigating the development of peptic ulcers in patients with liver cirrhosis reported that H. pylori is not the predominant etiology in this population.

Researchers in Taiwan report that type 2 diabetes is independently associated with increased risk of peptic ulcer bleeding.

Several studies recently have looked at the relationship between irritable bowel syndrome and increased pain sensitivity.

Study shows subtype of human stem cells can survive in the intestine and help replenish inflamed or damaged tissue.

A retrospective review of records from a large medical database finds that patients with sleep apnea face a substantially higher risk of developing peptic ulcer.

Study results show patients with IBS who drink four or more alcoholic drinks in one day may be more likely to experience diarrhea, nausea, stomach pain, and indigestion the next day.

Linzess (linaclotide capsules) was approved in August 2012 by the FDA as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

Women who suffer from celiac disease are more likely to report symptoms of depression and disordered eating, even if they follow a gluten-free diet, researchers have found.

Women with endometriosis are much more likely to develop inflammatory bowel disease than women without the reproductive disorder.

Radiofrequency treatment of patients with refractory gastroesophageal reflux disease appears to improve symptoms by decreasing compliance of the gastroesophageal junction, a new study suggests.

The death toll of the widely publicized listeria outbreak across the United States has risen from 13 to 18.

The FDA has approved Soliris (eculizumab) to treat pediatric and adult patients with atypical hemolytic uremic syndrome.

Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.

The primary endpoints have been met in a clinical trial of a drug for patients suffering from ulcerative colitis.

A researcher has proven that magnetic fields have the potential to act as a blood thinner, and possibly reduce the risk of heart attack.

Irregular periods in teenage girls may be linked to obesity, diabetes, reproductive issues, and heart disease.

The key to managing opioid-induced constipation is early recognition of the problem.

Low vaccination rates among patients with CLD and diabetes have grave public health implications.

Increased risk of clostridium difficile infection may be associated with exposure to linezolid and clindamycin.

Trial of mindfulness training as an intervention for irritable bowel syndrome (IBS) demonstrates substantial therapeutic impact on bowel symptom severity.

Scheduling, session topics, plenary speakers, and other information for physicians planning to attend DDW 2011.

The FDA has received reports that Teva's lansoprazole delayed-release orally disintegrating tablet has clogged and blocked oral syringes and feeding tubes.

Takeda announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors on Plavix

At Pri-Med Southwest, Frank Domino, MD, discussed the dangers of vitamin D deficiency and recommended screening and supplementation for at-risk patients.

John Goodson, MD, opened Pri-Med Southwest 2011 with a keynote address highlighting primary care innovation and advocacy and advice for future success.